The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaronsmead 2vt Regulatory News (BMD)

Share Price Information for Baronsmead 2vt (BMD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 55.50
Bid: 54.00
Ask: 57.00
Change: 0.00 (0.00%)
Spread: 3.00 (5.556%)
Open: 55.50
High: 55.50
Low: 55.50
Prev. Close: 55.50
BMD Live PriceLast checked at -
Baronsmead Second Venture Trust is an Investment Trust

To achieve long-term investment returns for private investors by investing primarily in a diverse portfolio of UK growth businesses, whether unquoted or traded on AIM.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on the Offer of Subscription

6 Mar 2020 14:56

RNS Number : 3282F
Baronsmead Second Venture Trust PLC
06 March 2020
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY JURISDICTION FOR WHICH THE SAME COULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA.

Baronsmead Second Venture Trust plc

6 March 2020

Update on the Offer for Subscription

The Board of Baronsmead Second Venture Trust plc (the "Company") announced on 4 October 2019 that it had published a Prospectus in conjunction with Baronsmead Venture Trust plc in relation to an offer for subscription to each raise up to £20 million (before costs) with an over-allotment facility to each raise up to a further £5 million (the "Offer").

On 27 February 2020 the Company carried out a third allotment of shares under the Offer, issuing 2,318,288 new ordinary shares of 10 pence each in the Company ("New Shares"). Subsequently, at the annual general meeting of the Company held on 27 February 2020, shareholders approved the payment of a final dividend of 3.5 pence per share (the "Final Dividend"). However, the net asset value as at 31 January 2020 did not take account of the Final Dividend and accordingly the net asset value used to calculate the issue price which the New Shares were issued at was overstated by the amount of the Final Dividend.

On the basis of the adjusted net asset value the Company has issued an additional 101,155 New Shares resulting in 2,419,443 New Shares being issued in the third allotment under the Offer at an issue price of 82.50 pence.

Applications have been made for the additional New Shares to be issued pursuant to the Offer to be admitted to the Official List (with a Premium Listing) and to the London Stock Exchange for the New Shares to be admitted to trading on the Main Market. It is expected that Admission will occur and dealing will commence in the additional New Shares to be issued pursuant to the Offer at 8.00 a.m. on 11 March 2020.

Share certificates and tax certificates in respect of the original issue of New Shares have not yet been issued. It is expected that share certificates and tax certificates showing the aggregate number of New Shares issued will be sent to the relevant Shareholders within 10 business days of the date of the allotment of the additional New Shares.

Total voting rights

Each Ordinary Share has one voting right. Following the issue of additional New Shares pursuant to the Offer, the Company will have 268,014,594 Ordinary Shares in issue (of which 22,750,063 Ordinary Shares are held in treasury). The total number of voting rights in the Company will therefore be 245,264,531 and this figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure and Transparency Rules.

Further information

For further information please contact.

Baronsmead VCT Investor Relations

020 3875 9862

baronsmeadvcts@greshamhouse.com

Notes

This announcement does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe or purchase, any investment in any jurisdiction, nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor.

The issue and the distribution of this announcement and the Prospectus in certain jurisdictions may be restricted by law and persons into whose possession any document or other information referred to in this announcement and the Prospectus comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEZQLFBBXLEBBZ
Date   Source Headline
5th Sep 201910:15 amRNSNet Asset Value(s)
8th Aug 20194:00 pmRNSDividend Declaration
8th Aug 20194:00 pmRNSIntention to Fundraise
6th Aug 20193:00 pmRNSNet Asset Value(s)
1st Aug 20195:28 pmRNSTotal Voting Rights
31st Jul 20192:05 pmRNSDirectorate Change
30th Jul 20195:21 pmRNSTransaction in Own Shares
10th Jul 20195:45 pmRNSNet Asset Value(s)
1st Jul 201911:44 amRNSTotal Voting Rights
27th Jun 20195:04 pmRNSTransaction in Own Shares
6th Jun 20195:20 pmRNSNet Asset Value(s)
3rd Jun 20197:00 amRNSTotal Voting Rights
29th May 20195:38 pmRNSTransaction in Own Shares
23rd May 20199:00 amRNSHalf-year Report
7th May 201910:30 amRNSNet Asset Value(s)
12th Apr 20194:00 pmRNSNet Asset Value(s)
1st Apr 20192:44 pmRNSTotal Voting Rights
28th Mar 20194:57 pmRNSTransaction in Own Shares
25th Mar 201910:34 amRNSDirector Declaration
8th Mar 201910:28 amRNSReplacement Transaction in Own Shares
7th Mar 20195:29 pmRNSTransaction in Own Shares
5th Mar 20194:00 pmRNSNet Asset Value(s)
1st Mar 201912:11 pmRNSTotal Voting Rights
28th Feb 20194:33 pmRNSResult of AGM
12th Feb 201912:44 pmRNSDirector/PDMR Shareholding - Replacement
8th Feb 20194:05 pmRNSDirector/PDMR Shareholding
7th Feb 20191:00 pmRNSIssue of New Shares
5th Feb 201910:45 amRNSNet Asset Value(s)
24th Jan 201911:30 amRNSNet Asset Value(s)
22nd Jan 20194:30 pmRNSOffer for Subscription - Update - Replacement
22nd Jan 20193:50 pmRNSOffer for Subscription - Update
9th Jan 20199:00 amRNSPublication of a Prospectus
2nd Jan 201911:50 amRNSTotal Voting Rights
21st Dec 20185:23 pmRNSTransaction in Own Shares
6th Dec 20183:30 pmRNSNet Asset Value(s)
3rd Dec 20183:42 pmRNSTotal Voting Rights
3rd Dec 20187:00 amRNSChange of Registered Office
27th Nov 20186:00 pmRNSTransaction in Own Shares
23rd Nov 20187:00 amRNSAnnual Financial Report y/e 30/09/2018
8th Nov 20185:09 pmRNSChange in management arrangements
6th Nov 20186:05 pmRNSNet Asset Value(s)
15th Oct 201812:15 pmRNSNet Asset Value(s)
1st Oct 201812:37 pmRNSTotal Voting Rights
27th Sep 20185:34 pmRNSTransaction in Own Shares
6th Sep 20184:00 pmRNSNet Asset Value(s)
3rd Sep 20189:28 amRNSTotal Voting Rights
31st Aug 20189:43 amRNSTransaction in Own Shares
9th Aug 20184:15 pmRNSDividend Declaration
9th Aug 20184:15 pmRNSIntention to Fundraise
7th Aug 201810:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.